154 related articles for article (PubMed ID: 27127060)
1. Nasal inserts containing ondansetron hydrochloride based on Chitosan-gellan gum polyelectrolyte complex: In vitro-in vivo studies.
Sonje AG; Mahajan HS
Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():329-335. PubMed ID: 27127060
[TBL] [Abstract][Full Text] [Related]
2. Nasal administration of ondansetron using a novel microspheres delivery system.
Mahajan HS; Gattani SG
Pharm Dev Technol; 2009; 14(2):226-32. PubMed ID: 19519195
[TBL] [Abstract][Full Text] [Related]
3. Formulation Development and Evaluation of Lyophilized Nasal Inserts for Migraine Treatment.
Harshada SD; Mundada AS
Recent Pat Drug Deliv Formul; 2017; 11(1):42-53. PubMed ID: 28103774
[TBL] [Abstract][Full Text] [Related]
4. Lyophilized Chitosan/xanthan Polyelectrolyte Complex Based Mucoadhesive Inserts for Nasal Delivery of Promethazine Hydrochloride.
G Dehghan MH; Marzuka M
Iran J Pharm Res; 2014; 13(3):769-84. PubMed ID: 25276178
[TBL] [Abstract][Full Text] [Related]
5. Nasal administration of ondansetron using a novel microspheres delivery system Part II: ex vivo and in vivo studies.
Mahajan HS; Gattani SG
Pharm Dev Technol; 2010 Dec; 15(6):653-7. PubMed ID: 20020823
[TBL] [Abstract][Full Text] [Related]
6. Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery.
Luppi B; Bigucci F; Abruzzo A; Corace G; Cerchiara T; Zecchi V
Eur J Pharm Biopharm; 2010 Aug; 75(3):381-7. PubMed ID: 20434556
[TBL] [Abstract][Full Text] [Related]
7. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V
J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761
[TBL] [Abstract][Full Text] [Related]
8. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form.
Bertram U; Bodmeier R
Eur J Pharm Sci; 2006 Jan; 27(1):62-71. PubMed ID: 16213127
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
[TBL] [Abstract][Full Text] [Related]
10. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.
Devkar TB; Tekade AR; Khandelwal KR
Colloids Surf B Biointerfaces; 2014 Oct; 122():143-150. PubMed ID: 25033434
[TBL] [Abstract][Full Text] [Related]
11. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
Salunke SR; Patil SB
Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
[TBL] [Abstract][Full Text] [Related]
12. Gellan gum based microparticles of metoclopromide hydrochloride for intranasal delivery: development and evaluation.
Mahajan HS; Gattani SG
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):388-92. PubMed ID: 19336933
[TBL] [Abstract][Full Text] [Related]
13. Polyelectrolyte complex of carboxymethyl gum katira-chitosan: Preparation and characterization.
Minkal ; Ahuja M; Bhatt DC
Int J Biol Macromol; 2018 Jan; 106():1184-1191. PubMed ID: 28851639
[TBL] [Abstract][Full Text] [Related]
14. Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts.
Bertram U; Bodmeier R
Drug Dev Ind Pharm; 2012 Jun; 38(6):659-69. PubMed ID: 22537309
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
[TBL] [Abstract][Full Text] [Related]
16. Thermally reversible xyloglucan gels as vehicles for nasal drug delivery.
Mahajan HS; Tyagi V; Lohiya G; Nerkar P
Drug Deliv; 2012; 19(5):270-6. PubMed ID: 22823894
[TBL] [Abstract][Full Text] [Related]
17. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of ondansetron nasal delivery systems.
Cho E; Gwak H; Chun I
Int J Pharm; 2008 Feb; 349(1-2):101-7. PubMed ID: 17822864
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability enhancement of ondansetron after nasal administration of Caesalpinia pulcherrima-based microspheres.
Suryawanshi SR; Thakare NP; More DP; Thombre NA
Drug Deliv; 2015; 22(7):894-902. PubMed ID: 24279581
[TBL] [Abstract][Full Text] [Related]
20. PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.
Karavasili C; Bouropoulos N; Sygellou L; Amanatiadou EP; Vizirianakis IS; Fatouros DG
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():1053-1062. PubMed ID: 26652464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
